Current perspectives on Lifileucel tumor-infiltrating lymphocyte therapy: A paradigm shift in immunotherapy.

Saved in:
Bibliographic Details
Title: Current perspectives on Lifileucel tumor-infiltrating lymphocyte therapy: A paradigm shift in immunotherapy.
Authors: Kaur SD; School of Pharmaceutical Sciences, Shoolini University of Biotechnology and Management Sciences, Solan 173229, India., Abubakar M; Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Hajipur, India., Bedi N; Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar 143005, India., Rao Puppala E; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland Baltimore School of Medicine, Baltimore, MD 21201, USA., Kapoor DN; School of Pharmaceutical Sciences, Shoolini University of Biotechnology and Management Sciences, Solan 173229, India. Electronic address: deepaknandkishore.558@shooliniuniversity.com., Kumar N; Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Hajipur, India. Electronic address: nitesh.kumar04@niperhajipur.ac.in., Ahemad N; School of Pharmacy, Monash University Malaysia, Jalan lagoon selatan, Petaling Jaya 46150, Selangor DE, Malaysia. Electronic address: nafees.ahemad@monash.edu., Anwar S; Department of Pharmacology and Toxicology, College of Pharmacy, University of Ha'il, Ha'il, Saudi Arabia.
Source: Current problems in cancer [Curr Probl Cancer] 2025 Dec; Vol. 59, pp. 101252. Date of Electronic Publication: 2025 Sep 12.
Publication Type: Journal Article; Review
Journal Info: Publisher: Mosby Country of Publication: United States NLM ID: 7702986 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-6345 (Electronic) Linking ISSN: 01470272 NLM ISO Abbreviation: Curr Probl Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1535-6345
DOI:10.1016/j.currproblcancer.2025.101252